Study examines how different imaging criteria can be used to assess brain tumor responses in patients with melanoma: Modified imaging approach (mRECIST) and volumetric measurements (3D size analysis) were more accurate in predicting survival compared to other methods
Study examines how different imaging criteria can be used to assess brain tumor responses in patients with melanoma: Modified imaging approach (mRECIST) and volumetric measurements (3D size analysis) were more accurate in predicting survival compared to other methods